Last updated: August 16, 2026

Application No. 18/702,752

COMPOSITIONS COMPRISING AN ERK INHIBITOR

Non-Final OA

Filed

Apr 18, 2024

Priority

Oct 26, 2021 — provisional 63/271,977 +1 more

Examiner

SONG, JIANFENG

Art Unit

1613

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Otsuka Pharmaceutical Co., Ltd.

OA Round

1 (Non-Final)

This examiner grants 56% of cases after interview

— +33.1% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 858 resolved cases, 2023–2026

Examiner Intelligence

SONG, JIANFENG View full profile →

Grants 56% of resolved cases

Career Allowance Rate

482 granted / 858 resolved

-3.8% vs TC avg

Strong +33% interview lift

Without

With

+33.1%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

66 currently pending

Career history

929

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

48.4%

+8.4% vs TC avg

§102

10.2%

-29.8% vs TC avg

§112

17.8%

-22.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 858 resolved cases

Prosecution Timeline

Apr 18, 2024

Application Filed

Jul 31, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/750,367

Patent 12702136

SURFACE DISINFECTANT FORMULATION

4y 2m to grant Granted Aug 11, 2026

18/270,763

Patent 12678398

ULTRAVIOLET LIGHT-BLOCKING COMPOSITION COMPRISING CENTIPEDE GRASS EXTRACT AND COSMETIC COMPOSITION COMPRISING SAME

3y 0m to grant Granted Jul 14, 2026

18/089,134

Patent 12661335

Halogenated Xanthene-Containing Topical Anti-Gram-Positive Bacterial Ophthalmic Composition and Method

3y 5m to grant Granted Jun 23, 2026

18/169,553

Patent 12661339

METHODS FOR TREATING OCULAR DEMODEX USING SPINOSAD FORMULATIONS

3y 4m to grant Granted Jun 23, 2026

17/777,225

Patent 12636410

TISSUE RESTORATION COMPOSITION

4y 0m to grant Granted May 26, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

56%

Grant Probability

89%

With Interview (+33.1%)

2y 7m (~3m remaining)

Median Time to Grant

Low

PTA Risk

Based on 858 resolved cases by this examiner. Grant probability derived from career allowance rate.